AbbVie to acquire Allergan for $63 billion
AbbVie and Allergan announced an agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie's common stock of $78.45 on June 24, 2019. June 25, 2019